优化治疗:昼夜节律和药物时间对转化率和生存率的影响
1Department of First Clinical Medicine, Shaanxi University of Chinese Medicine, Xian Yang, China.
QJM : monthly journal of the Association of Physicians
|August 21, 2024
概括
昼夜节律影响了从发作到状态 (SE) 的进展. 在特定时间,特别是夜间早些时候服用抗药物 (AED),可以减少SE转化并改善患者的存活率.
科学领域:
- 神经学 神经学
- 时间生物学 时间生物学
- 关键护理医学 关键护理医学
背景情况:
- 状态 (SE) 是孤立发作的一个关键进展.
- 了解影响SE转换的因素对于患者的治疗结果至关重要.
- 循环节律越来越多地被认为是神经事件的调节器.
研究的目的:
- 确定从孤立发作过渡到SE的昼夜模式.
- 评估抗药物 (AED) 定时对SE转换率的影响.
- 评估药物治疗时间是否会影响SE患者的存活率.
主要方法:
- 使用eICU协作研究数据库v2.0.0.2进行SE风险患者的回顾性分析.
- 与昼夜节律相对应的SE转换时间和AED管理的相关性分析.
- 逻辑模型用于评估药物定时对SE转化和生存的影响.
主要成果:
- 在从发作过渡到SE时,观察到明显的昼夜模式,并延迟了缩期.
- 早在夜间服用AED显著降低了SE转换率.
- 药物治疗时间表明对生存率有影响,在特定的昼夜周期中改善了结果.
结论:
- 昼夜节律在从孤立的发作到SE的进展中发挥着重要作用.
- 优化AED的使用时间对于减少SE转换和提高生存率至关重要.
- 一种慢性治疗方法,将AED与个体的昼夜脆弱性保持一致,可能会促进重症监护室的管理.
相关概念视频
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
49
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
49
Management of Insomnia
237
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
237
Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
275
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
275
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Antiepileptic Drugs: GABAergic Pathway Potentiators
358
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
358


